Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, Kaposi sarcoma
Stage/Subtype:  classic Kaposi sarcoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-3 of 3 for your search:
Start Over
Pomalidomide in Treating Patients with Kaposi Sarcoma with or without HIV
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0047, NCI-2013-01525, 120047, P11847, PO-KS-NCI-0050, NCT01495598
Pegylated Liposomal Doxorubicin Hydrochloride and Bevacizumab in Treating Patients with Advanced Kaposi Sarcoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 09-C-0130, NCI-2013-01450, 090130, NCT00902239, P09493, NCT00923936
Nelfinavir Mesylate in Treating Patients with Epstein-Barr Virus or Kaposi Sarcoma-Associated Herpesvirus Positive Malignancies
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J13174, NCI-2014-01534, NA_00092477, NA _00092477 / CIR00004163, NCT02080416
Start Over